Related Experiment Videos
[The Infucommand. A PCA (patient-controlled analgesia) device using pulsoximetric bolus control]
1Institut für Anaesthesiologie, Ludwig-Maximilians-Universität, München.
Der Anaesthesist
|April 1, 1990
Summary
Physician-controlled analgesia (PCA) can lead to respiratory depression. A new device, Infucommand, uses a pulsoximeter to monitor oxygen saturation and halts medication delivery if levels drop, reducing opioid overdose risks.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Context:
- Patient-controlled analgesia (PCA) is widely used for pain management.
- Unnoticed respiratory depression is a significant risk associated with PCA.
- Opioid overdose is a serious complication that requires vigilant monitoring.
Purpose:
- To introduce a novel safety device for PCA.
- To mitigate the risk of respiratory depression during PCA.
Summary:
- A new device, Infucommand, integrates a pulsoximeter with the PCA infusion pump.
- It continuously monitors blood oxygen saturation (SpO2).
- The device automatically stops the infusion if SpO2 falls below a predetermined threshold, preventing opioid overdose.
Impact:
- Enhances patient safety during PCA therapy.
- Provides real-time respiratory monitoring, reducing adverse events.
- Offers physicians a tool to manage PCA risks more effectively.